ADVERSE EFFECTS
Clinical trials for ADVERSE EFFECTS explained in plain language.
Never miss a new study
Get alerted when new ADVERSE EFFECTS trials appear
Sign up with your email to follow new studies for ADVERSE EFFECTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for transplant patients: drug combo may tame deadly immune attack
Disease control Recruiting nowThis study tests a drug called ruxolitinib for treating acute graft-versus-host disease (GVHD), a serious condition where donor cells attack the patient's body after a bone marrow transplant. About 98 adults with moderate to severe GVHD will receive either ruxolitinib alone or wi…
Matched conditions: ADVERSE EFFECTS
Phase: PHASE2 • Sponsor: John Levine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a phone app cut PICC complications? new study aims to find out.
Knowledge-focused Recruiting nowThis study looks at whether a smartphone app called SpadCare can help patients who have a PICC line (a thin tube for giving medicine or nutrition) take better care of it at home. About 201 adults will either use the app or get standard care. The goal is to see if app users have f…
Matched conditions: ADVERSE EFFECTS
Phase: NA • Sponsor: Fundacion Miguel Servet • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:30 UTC